Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Saudi Arabia

Saudi Arabia Articles

Industry

BMI View: Diabetes and cardiovascular diseases are the Middle East and North Africa (MENA)'s biggest epidemiological challenge. The underlying cause of these diseases is obesity. The... 2012-02-06


Industry

BMI View: Attempts in the Gulf region to take a more preventative stance against public health issues is commendable, but changing attitudes and weaning the population of their tobacco... 2012-02-01


Industry

BMI View: It can be difficult to substantially increase healthcare spending overnight without building new social infrastructure and developing better human resources, which is a lengthy... 2012-01-03


More ARTICLES

Industry

BMI View: We like Julphar's regional strategy, especially its diversified product portfolio with sales across the Middle East and North Africa (MENA). Their joint venture with Cigalah... 2011-11-24


Industry

BMI View: While not an easily commercialised event, the hajj pilgrimage to Mecca is an enormous healthcare challenge requiring huge volumes of vaccines, over-the-counter (OTC) drugs... 2011-11-17


Industry

BMI View: While the biotechnology parks of Dubai and Saudi Arabia have attracted some big names in the global industry, we are concerned that they may have become glorified tax havens... 2011-11-09


Industry

BMI View: The rise of lifestyle diseases associated with obesity and the relatively high per capita spending of the Gulf Cooperation Council (GCC) countries is going to attract medical... 2011-10-26


Industry

BMI View: A free trade agreement (FTA) between India and the Gulf Cooperation Council (GCC) will help Indian drugmakers to take a greater market share of the generic drug segment, primarily... 2011-10-13

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries